Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...

STOCKHOLM, SE / ACCESS Newswire / April 7, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® ...

The ASX has been down 1.5% at 7,739 points this morning. There’s been carnage on the ASX and the Energy sector has been ...

Austin City Limits Celebrates 50 Years honors the fifty year-legacy of the longest-running music television series in history with live performances by diverse artists, vintage archival clips, ...

Scientists have re-created a pain pathway in the brain by growing four key clusters of human nerve cells in a dish. This ...

The Phase 4 ENABLE study is set to be first in the U.S. to collect real-world safety and efficacy data of Briumvi for ...

Scientists created a model of the human pain pathway in a dish by connecting four separate brain organoids. The feat should help them understand sensory disorders like those affecting pain perception.

“Last week, we celebrated the talent and dedication of students and postdocs in stem cell research who are honored with the Outstanding Poster Award,” Fiona Doetsch, PhD, co-chair of the ISSCR ...

Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells ... the ganglioside GD2 and CD271 (low-affinity nerve growth factor receptor), and they are recognized ...